Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

The Market Online’s Weekly Cannabis Report – April 19, 2024

Jonathon Brown Jonathon Brown, The Market Online
0 Comments| 13 days ago

{{labelSign}}  Favorites
{{errorMessage}}

After rearranging its capital structure, Canopy Growth will be closer to establishing a U.S.-based multi state operator. Shareholders overwhelmingly approved the creation of a new class of exchangeable shares of the cannabis company, which could enable the acceleration of its entry into the U.S. THC market.

Click to enlarge
(Source: Canopy Growth Corp.).

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Top Story: cannabis cultivation and product company receives second CBD approval by Mexican authority

2 | Tilray lights up 420 with music festivals and celebrations across the country

3 | Certification begins into the contactless marijuana and alcohol breathalyzer

Click to enlarge

Top Cannabis Stocks April 12 to April 18, 2024

1. T.WEED | 23,432 views | Canopy Growth Corp.
2. T.TLRY | 19,281 views | Tilray Brands Inc.
3.T.LABS | 8,256 views | Medipharm Labs Corp.
4. T.CURA | 4,287 views | Curaleaf Holdings Inc.
5. T.OGI | 2,383 views | OrganiGram Holdings Inc.
6.T.ACB| 2,127 views | Aurora Cannabis Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.



{{labelSign}}  Favorites
{{errorMessage}}